Vancomycin-Resistant Enterococcus faecalis Endocarditis: Linezolid Failure and Strain Characterization of Virulence Factors
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Infective endocarditis due to vancomycin-resistant (VR) Enterococcus faecalis has only rarely been reported. We report a case of VR E. faecalis endocarditis that failed to respond to linezolid therapy, outline the virulence traits of the isolate, and review previously published cases of VR E. faecalis endocarditis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, linezolid treatment failures of E faecium IE also were reported.206”
In the citing paper
“The HACEK group is usually susceptible in vitro to fluoroquinolones.206”
Citations
Cites
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027 · cited 1×
“criteria for definite or possible infective endocarditis (13).”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 2×
“faecalis isolates in the United States (5, 8).”
BackgroundRole of Mobile DNA in the Evolution of Vancomycin-Resistant Enterococcus faecalis
Paulsen, I. T., Banerjei, L., Myers, G. S. A., Nelson, K. E., Seshadri, R., Read, T. D., Fouts, D. E., Eisen, J. A., Gill, S. R., Heidelberg, J. F., et al. (2003) · Science · doi:10.1126/science.1080613 · Cited by 930 · cited 1×
“a The DNA probe for the esp gene was amplified from strain MMH594, and those for all other genes were amplified from V583 (19).”
BackgroundMultiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future
Huycke, M. M., Sahm, D. F., & Gilmore, M. S. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980211 · Cited by 718 · cited 2×
“faecalis isolates in the United States (5, 8).”
BackgroundThe Enterococcal Surface Protein, Esp, Is Involved in Enterococcus faecalis Biofilm Formation
Toledo-Arana, A., Valle, J., Solano, C., Arrizubieta, M. J., Cucarella, C., Lamata, M., Amorena, B., Leiva, J., Penadés, J. R., & Lasa, I. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.10.4538-4545.2001 · Cited by 605
Shankar, V., Baghdayan, A. S., Huycke, M. M., Lindahl, G., & Gilmore, M. S. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.193-200.1999 · Cited by 435
Endocarditis and biofilm-associated pili of Enterococcus faecalis
Nallapareddy, S. R., Singh, K. V., Sillanpaa, J., Garsin, D. A., Hook, M., Erlandsen, S. L., & Murray, B. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29021 · Cited by 412 · cited 1×
“These included the gelatinase gene (22, 26, 28, 30); recently described pilus-encoding genes (16); genes encoding putative MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) with predicted immunoglobulin (Ig)-like folds (17, 18, 27; J.”
BackgroundSelf-citationModulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis
Shankar, N., Baghdayan, A. S., & Gilmore, M. S. (2002) · Nature · doi:10.1038/nature00802 · Cited by 393 · cited 1×
“pothetical protein, and others (15, 24); hyaluronidases (15);”
BackgroundQin, X., Singh, K. V., Weinstock, G. M., & Murray, B. E. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2579-2586.2000 · Cited by 364 · cited 2×
“The strain was examined for phenotypic production of gelatinase (22), hemolytic activity on Bacto Tryptic Soy Agar (Becton Dickinson and Company, Sparks, MD) plus 5% human blood agar plates, and biofilm formation (14).”
BackgroundMethodSelf-citationMohamed, J. A., Huang, W., Nallapareddy, S. R., Teng, F., & Murray, B. E. (2004) · Infection and Immunity · doi:10.1128/iai.72.6.3658-3663.2004 · Cited by 297 · cited 1×
“The strain was examined for phenotypic production of gelatinase (22), hemolytic activity on Bacto Tryptic Soy Agar (Becton Dickinson and Company, Sparks, MD) plus 5% human blood agar plates, and biofilm formation (14).”
MethodSelf-citation
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“However, linezolid treatment failures of E faecium IE also were reported.(206)”
BackgroundSelf-citationGould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Crank, C., & O'Driscoll, T. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s54125 · Cited by 505
“It has successfully treated several VRE IE cases, but treatment failures have also been reported.(39,80) Linezolid has good urine penetration at roughly 40%, but this decreases dramatically in renal dysfunction.”
Management of multidrug-resistant enterococcal infections
Arias, C. A., Contreras, G. A., & Murray, B. E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03214.x · Cited by 388
“1) [49–51].”
Self-citationEmergence and management of drug-resistant enterococcal infections
Arias, C. A., & Murray, B. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.637 · Cited by 294
Self-citation
Metadata
- Authors
- Tsigrelis, C., Singh, K. V., Coutinho, T. D., Murray, B. E., & Baddour, L. M.
- Affiliations
- Mayo Clinic (US)
- Division of Infectious Diseases, Department of Medicine
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Tsigrelis, Constantine
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2007-02
- Volume
- 45
- Issue
- 2
- Pages
- 631-635
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC1829077
- OpenAlex
- W1984425763
- Semantic Scholar
- 641ef3c32c510a702f5bb29c5d2b0a0f1f9f0a0c
- Cited by
- 48
- References
- 36
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 7 · 2014: 2 · 2013: 1 · 2012: 3
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R37AI47923, R37AI047923)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- vancomycin-resistant Enterococcus faecalis, infective endocarditis, virulence factors, antimicrobial resistance, strain characterization
- MeSH terms
- Linezolid, Acetamides, Adult, Anti-Infective Agents, Bacterial Proteins, Endocarditis, Bacterial, Female, Humans, Enterococcus faecalis, Virulence, Gram-Positive Bacterial Infections, Treatment Failure, Vancomycin Resistance, Oxazolidinones, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vancomycin-Resistant Enterococcus faecalis Endocarditis: Linezolid Failure and Strain Characterization of Virulence Factors. https://app.cochat.ai/papers/10.1128/jcm.02188-06
- The paper
- Tsigrelis, C., Singh, K. V., Coutinho, T. D., Murray, B. E., & Baddour, L. M. (2007). Vancomycin-Resistant Enterococcus faecalis Endocarditis: Linezolid Failure and Strain Characterization of Virulence Factors. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.02188-06
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.